Emil Kakkis
Founder en ULTRAGENYX PHARMACEUTICAL INC. .
Fortuna: 132 M $ al 31/03/2024
Perfil
Emil D. Kakkis fundó Ultragenyx Pharmaceutical, Inc. y Everylife Foundation for Rare Diseases. El Dr. Kakkis ocupa el cargo de Presidente, Director General y Director de Ultragenyx Pharmaceutical, Inc. El Dr. Kakkis también forma parte del consejo de Emil Kakkis & Jenny Soriano Living Trust y de Odylia Therapeutics y es presidente de la Everylife Foundation for Rare Diseases. En su anterior carrera, el Dr. Kakkis fue director médico y vicepresidente senior de BioMarin Pharmaceutical, Inc. y profesor adjunto en el Centro Médico Harbor-UCLA. El Dr. Kakkis se licenció en el Pomona College y se doctoró en la Facultad de Medicina David Geffen.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2024 | 2 827 898 ( 3.43% ) | 132 M $ | 31/03/2024 |
Cargos activos de Emil Kakkis
| Empresas | Cargo | Inicio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Founder | 22/04/2010 |
| Emil Kakkis & Jenny Soriano Living Trust | Director/Board Member | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Founder | 01/03/2009 |
| Odylia Therapeutics | Director/Board Member | 01/01/2019 |
Antiguos cargos conocidos de Emil Kakkis.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 27/02/2009 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Corporate Officer/Principal | 01/01/1998 |
Formación de Emil Kakkis.
| Pomona College | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Health Services |
| Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Commercial Services |
| Odylia Therapeutics |
- Bolsa de valores
- Insiders
- Emil Kakkis
